sales@theinsightpartners.com
+1-646-491-9876 +44-20-8125-4005

Asia Pacific Rare Neurological Disease Treatment Market Scope And Analysis

  • Report Code : TIPRE00010243
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 147
Buy Now

Asia Pacific Rare Neurological Disease Treatment Market Scope, Growth, Size and Share by 2027

Buy Now

Asia Pacific Rare Neurological Disease Treatment Market Report Asia Pacific Rare Neurological Disease Treatment Market Size and Share Asia Pacific Rare Neurological Disease Treatment Market Scope and Analysis

Asia Pacific Rare Neurological Disease Treatment Market Report Scope

Report Attribute Details
Market size in 2019 US$ 1,225.38 Million
Market Size by 2027 US$ 2,437.02 Million
Global CAGR (2019 - 2027) 9.2%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By Indication
  • Narcolepsy
  • Amyotrophic Lateral Sclerosis
  • Alzheimer
By Drug Type
  • Organic Compounds
  • Biologics
By Distribution Channel
  • Online Pharmacies
  • Hospital Pharmacies
  • Retail Pharmacies
By Mode of Administration
  • Oral
  • Injectables
Regions and Countries Covered Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
Market leaders and key company profiles
  • Allergan plc
  • Bayer AG
  • GlaxoSmithKline plc
  • Johnson Johnson Services Inc
  • Merck Co Inc
  • Novartis AG
  • Pfizer Inc
  • Sanofi